188 related articles for article (PubMed ID: 32422263)
1. A single injection of bleomycin reduces glycosaminoglycan sulfation up to 30 days in the C57BL/6 mouse model of lung fibrosis.
Lan Y; Liu Y; He Y; Liu F; Xv H; Feng K; Zhang Z; Shi Z; Zhang X; Zhang L
Int J Biol Macromol; 2020 Oct; 160():319-327. PubMed ID: 32422263
[TBL] [Abstract][Full Text] [Related]
2. Heparan Sulfate and Chondroitin Sulfate Glycosaminoglycans Are Targeted by Bleomycin in Cancer Cells.
Li X; Lan Y; He Y; Liu Y; Luo H; Yu H; Song N; Ren S; Liu T; Hao C; Guo Y; Zhang L
Cell Physiol Biochem; 2017; 43(3):1220-1234. PubMed ID: 28982096
[TBL] [Abstract][Full Text] [Related]
3. Increased deposition of chondroitin/dermatan sulfate glycosaminoglycan and upregulation of β1,3-glucuronosyltransferase I in pulmonary fibrosis.
Venkatesan N; Ouzzine M; Kolb M; Netter P; Ludwig MS
Am J Physiol Lung Cell Mol Physiol; 2011 Feb; 300(2):L191-203. PubMed ID: 21056957
[TBL] [Abstract][Full Text] [Related]
4. Increased deposition of glycosaminoglycans and altered structure of heparan sulfate in idiopathic pulmonary fibrosis.
Westergren-Thorsson G; Hedström U; Nybom A; Tykesson E; Åhrman E; Hornfelt M; Maccarana M; van Kuppevelt TH; Dellgren G; Wildt M; Zhou XH; Eriksson L; Bjermer L; Hallgren O
Int J Biochem Cell Biol; 2017 Feb; 83():27-38. PubMed ID: 27974233
[TBL] [Abstract][Full Text] [Related]
5. Pingyangmycin inhibits glycosaminoglycan sulphation in both cancer cells and tumour tissues.
Lan Y; Li X; Liu Y; He Y; Hao C; Wang H; Jin L; Zhang G; Zhang S; Zhou A; Zhang L
J Cell Mol Med; 2020 Mar; 24(6):3419-3430. PubMed ID: 32068946
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Glycosaminoglycan Disaccharide Composition in Astrocyte Primary Cultures and the Cortex of Neonatal Rats.
Zhang X; Hashimoto JG; Han X; Zhang F; Linhardt RJ; Guizzetti M
Neurochem Res; 2021 Mar; 46(3):595-610. PubMed ID: 33398638
[TBL] [Abstract][Full Text] [Related]
7. Glycosyltransferases and glycosaminoglycans in bleomycin and transforming growth factor-β1-induced pulmonary fibrosis.
Venkatesan N; Tsuchiya K; Kolb M; Farkas L; Bourhim M; Ouzzine M; Ludwig MS
Am J Respir Cell Mol Biol; 2014 Mar; 50(3):583-94. PubMed ID: 24127863
[TBL] [Abstract][Full Text] [Related]
8. Glycosaminoglycans and glycolipids as potential biomarkers in lung cancer.
Li G; Li L; Joo EJ; Son JW; Kim YJ; Kang JK; Lee KB; Zhang F; Linhardt RJ
Glycoconj J; 2017 Oct; 34(5):661-669. PubMed ID: 28822024
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Disaccharide Profiling of Glycosaminoglycans from Two Different Preparations by PMP and Deuterated PMP Labeling.
Zhang M; An Y; Zhang L
Methods Mol Biol; 2022; 2303():111-119. PubMed ID: 34626374
[TBL] [Abstract][Full Text] [Related]
10. Regional and disease-specific glycosaminoglycan composition and function in decellularized human lung extracellular matrix.
Hoffman E; Song Y; Zhang F; Asarian L; Downs I; Young B; Han X; Ouyang Y; Xia K; Linhardt RJ; Weiss DJ
Acta Biomater; 2023 Sep; 168():388-399. PubMed ID: 37433361
[TBL] [Abstract][Full Text] [Related]
11. Isolation and structural characterization of bioactive glycosaminoglycans from the green-lipped mussel Perna canaliculus.
Mubuchi A; Katsumoto S; Tsuboi M; Ishikawa H; Nomura Y; Higashi K; Miyata S
Biochem Biophys Res Commun; 2022 Jul; 612():50-56. PubMed ID: 35504089
[TBL] [Abstract][Full Text] [Related]
12. Comparative glycomics of leukocyte glycosaminoglycans.
Shao C; Shi X; White M; Huang Y; Hartshorn K; Zaia J
FEBS J; 2013 May; 280(10):2447-61. PubMed ID: 23480678
[TBL] [Abstract][Full Text] [Related]
13. Changes in glycosaminoglycan characteristics during progression of a human gingival carcinoma xenograft line in nude mice.
Ida M; Kamada A
J Osaka Dent Univ; 1995 Oct; 29(2):39-50. PubMed ID: 8941754
[TBL] [Abstract][Full Text] [Related]
14. Improved workup for glycosaminoglycan disaccharide analysis using CE with LIF detection.
Hitchcock AM; Bowman MJ; Staples GO; Zaia J
Electrophoresis; 2008 Nov; 29(22):4538-48. PubMed ID: 19035406
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of glycosaminoglycans, chondroitin/dermatan sulfate, hyaluronic acid, heparan sulfate, and keratan sulfate by liquid chromatography-electrospray ionization-tandem mass spectrometry.
Osago H; Shibata T; Hara N; Kuwata S; Kono M; Uchio Y; Tsuchiya M
Anal Biochem; 2014 Dec; 467():62-74. PubMed ID: 25197028
[TBL] [Abstract][Full Text] [Related]
16. A method for characterising human intervertebral disc glycosaminoglycan disaccharides using liquid chromatography-mass spectrometry with multiple reaction monitoring.
Liu X; Krishnamoorthy D; Lin L; Xue P; Zhang F; Chi L; Linhardt RJ; Iatridis JC
Eur Cell Mater; 2018 Feb; 35():117-131. PubMed ID: 29469163
[TBL] [Abstract][Full Text] [Related]
17. Disaccharide analysis of glycosaminoglycans using hydrophilic interaction chromatography and mass spectrometry.
Gill VL; Aich U; Rao S; Pohl C; Zaia J
Anal Chem; 2013 Jan; 85(2):1138-45. PubMed ID: 23234263
[TBL] [Abstract][Full Text] [Related]
18. Analysis of procainamide-derivatised heparan sulphate disaccharides in biological samples using hydrophilic interaction liquid chromatography mass spectrometry.
Antia IU; Mathew K; Yagnik DR; Hills FA; Shah AJ
Anal Bioanal Chem; 2018 Jan; 410(1):131-143. PubMed ID: 29098336
[TBL] [Abstract][Full Text] [Related]
19. Allergen-induced airway remodeling in brown norway rats: structural and metabolic changes in glycosaminoglycans.
Venkatesan N; Siddiqui S; Jo T; Martin JG; Ludwig MS
Am J Respir Cell Mol Biol; 2012 Jan; 46(1):96-105. PubMed ID: 21852687
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic carcinoma is characterized by elevated content of hyaluronan and chondroitin sulfate with altered disaccharide composition.
Theocharis AD; Tsara ME; Papageorgacopoulou N; Karavias DD; Theocharis DA
Biochim Biophys Acta; 2000 Oct; 1502(2):201-6. PubMed ID: 11040445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
